3-苯基戊酸 | 5669-17-0

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 苯丙酸
• 中文名称: 3-苯基戊酸
• 英文名称: 3-phenylpentanoic acid
• 英文别名: 2-phenylbutane carboxylic acid
• CAS: 5669-17-0
• 化学式: C₁₁H₁₄O₂
• mdl: MFCD01722151
• 分子量: 178.231
• InChiKey: NJEKDDOCPZKREE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.363
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2916399090

反应信息

• 作为反应物：
  描述：

  3-苯基戊酸 在 lithium aluminium tetrahydride 作用下， 以 乙醚 为溶剂， 以93%的产率得到(+/-)-3-phenyl-1-pentanol
  参考文献：
  名称：

  Lipase catalyzed acylation of primary alcohols with remotely located stereogenic centres: the resolution of (±)-4,4-dimethyl-3-phenyl-1-pentanol

  摘要：

  Enantio selective acylation of some(+/-)-3-alkyl-3-phenyl-1-propanols was performed with enzymes as catalysts. Moderate enantiomeric ratios (E), ranging up to E = 11.6, were obtained. In the resolution, some of the lipases selectively acylated the (+)-enantiomer while others acylated the (-)-enantiomer of the gamma-substituted primary alcohols 1-4. Thus, it is possible to obtain both enantiomers of the alcohols as remaining substrate with high enantiomeric purity. The resolution of (+/-)-4,4-dimethyl-3-phenyl-1-pentanol 4 was extensively studied and screening experiments were conducted to select suitable lipase(s), reaction medium, acyl donor and appropriate temperature combinations to increase the enantiomeric ratio. Chirazyme (R) L-6/chloroform/vinyl propionate/38 degrees C and Chirazyme (R) L-7/di-iso-propyl ether/vinyl propionate/0 degrees C were chosen to obtain both enantiomers, (R)-(+)-4 and (S)-(-)-4, respectively, via sequential resolutions in excellent enantiomeric excess (> 98%) and in 25% and 22% yield, respectively. (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetasy.2007.07.002
• 作为产物：
  描述：

  亚苯甲基丙二酸二乙酯 在 氢氧化钾 、 乙醚 作用下， 生成 3-苯基戊酸
  参考文献：
  名称：

  Reynolds, American Chemical Journal, 1910, vol. 44, p. 321

  摘要：

  DOI：

文献信息

• Biphenyl derivatives, production thereof and uses as medicines
  申请人：Boehringer Ingelheim Pharma KG

  公开号：US06617325B1

  公开（公告）日：2003-09-09

  The present invention relates to biphenyl derivatives of general formula wherein Ra to Rg and n are defined as in claim 1, the isomers and salts thereof, particularly the physiologically acceptable salts thereof, which are valuable inhibitors of the microsomal triglyceride-transfer protein (MTP), medicaments containing these compounds and their use, as well as the preparation thereof.

  本发明涉及通式为的联苯衍生物，其中Ra至Rg和n的定义如权利要求1所述，其同分异构体和盐，尤其是具有生理活性的盐，这些盐是对微粒体甘油三酯转移蛋白（MTP）的有效抑制剂，包含这些化合物的药物及其用途，以及它们的制备方法。
• Identification of an Esterase Isolated Using Metagenomic Technology which Displays an Unusual Substrate Scope and its Characterisation as an Enantioselective Biocatalyst
  作者：Declan P. Gavin、Edel J. Murphy、Aoife M. Foley、Ignacio Abreu Castilla、F. Jerry Reen、David F. Woods、Stuart G. Collins、Fergal O'Gara、Anita R. Maguire

  DOI：10.1002/adsc.201801691

  日期：2019.6.6

  Evaluation of an esterase annotated as 26D isolated from a marine metagenomic library is described. Esterase 26D was found to have a unique substrate scope, including synthetic transformations which could not be readily effected in a synthetically useful manner using commercially available enzymes. Esterase 26D was more selective towards substrates which had larger, more sterically demanding substituents

  描述了评估从海洋宏基因组库中分离为26D的酯酶的方法。发现酯酶26D具有独特的底物范围，包括使用市售酶不易以合成有用的方式实现的合成转化。酯酶26D是更具选择性的朝向具有较大的，更空间要求的取代基的底物（即，异-丙基或叔-丁基基团）上的β碳，这是相对于其中显示的偏好基板与空间位先前测试的市售的酶β-碳原子上的取代基（例如甲基）要求较低。
• Pharmacological characterization of a new series of carbamoylguanidines reveals potent agonism at the H2R and D3R
  作者：Sabrina Biselli、Merlin Bresinsky、Katharina Tropmann、Lisa Forster、Claudia Honisch、Armin Buschauer、Günther Bernhardt、Steffen Pockes

  DOI：10.1016/j.ejmech.2021.113190

  日期：2021.3

  selectivity profile towards the hH2R, e.g. 157 being at least 3800-fold selective within the histamine receptor family. The structural similarities of our monomeric ligands to pramipexole (6), a dopamine receptor agonist, suggested an investigation of the binding behavior at those receptors. The target compounds were (partial) agonists with moderate affinity at the hD2longR and agonists with high affinity

  即使在今天，组胺H 2受体（H 2 R）在中枢神经系统（CNS）中的作用仍然广为人知。在先前的研究中，许多二聚体，高亲和力和亚型选择性的氨基甲酰基胍型配体，例如UR-NK22（5，p K i  = 8.07）被报道为H 2 R激动剂。但是，它们在中枢神经系统中研究H 2 R的适用性因其分子和药代动力学特性（例如高分子量）而受到限制，因此其生物利用度有限。满足对更多类似毒品的H 2的需求R激动剂具有高亲和力，我们合成了一系列含有各种间隔基和侧链部分的单体（硫代）氨基甲酰基胍型配体。这种结构上的简化导致了有效的（部分）激动剂（豚鼠右心房，[ 35 S]GTPγS和β-arrestin2募集试验），其人类（h）H 2 R亲和力在一位纳摩尔范围内（p K i（139，UR-KAT523）：8.35； p K i（157，UR-MB-69）：8.69）。本文介绍的大多数化合物对hH 2 R表现出出色
• Norrish type II reactions of acyl azolium salts
  作者：Andreas Mavroskoufis、Arielle Rieck、Matthew N. Hopkinson

  DOI：10.1016/j.tet.2021.132497

  日期：2021.11

  in N-heterocyclic carbene (NHC) organocatalysis, undergo Norrish type II elimination reactions under irradiation with UVA light in analogy to structurally related aromatic ketones. Moreover, efficient Norrish-Yang cyclization was observed from an adamantyl-substituted derivative. These results further demonstrate the ability of NHCs to influence the absorption properties and photochemical reactivity

  已经研究了衍生自脂肪族羧酸的酰基唑盐的光化学反应性。这些物种作为 N-杂环卡宾 (NHC) 有机催化中生成的中间体的模型，在 UVA 光照射下进行 Norrish II 型消除反应，类似于结构相关的芳香酮。此外，从金刚烷基取代的衍生物中观察到有效的 Norrish-Yang 环化。这些结果进一步证明了 NHCs 在催化循环过程中影响羰基的吸收特性和光化学反应性的能力。
• [EN] PYRIMIDINE COMPOUNDS THAT INHIBIT ANAPLASTIC LYMPHOMA KINASE<br/>[FR] COMPOSÉS PYRIMIDINE QUI INHIBENT LA KINASE DU LYMPHOME ANAPLASIQUE
  申请人：AMGEN INC

  公开号：WO2011143033A1

  公开（公告）日：2011-11-17

  Compounds of Formula I are useful inhibitors of anaplastic lymphoma kinase. Compounds of Formula I have the following structure: where the definitions of the variables are provided herein.

  Formula I的化合物是一种有用的间变性淋巴瘤激酶抑制剂。Formula I的化合物具有以下结构：变量的定义在此提供。

表征谱图